Routine susceptibility tests with ticarcillin and tobramycin in combination should be more appropriate than with each antibiotic alone in cystic fibrosis Pseudomonas aeruginosa.
Lapointe
J R
JR
Pediatric Research Center and Department of Microbiology and Immunology, Université de Montréal and Hôpital Sainte-Justine, Montreal, Quebec, Canada.
Bourget
C
C
Mainville
S
S
Lafleur
L
L
Lagacé
J
J
Montplaisir
S
S
D000900:Anti-Bacterial Agents / Q000097:blood / Q000494:pharmacology*; D003550:Cystic Fibrosis / Q000382:microbiology*; D004359:Drug Therapy, Combination; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods; D011552:Pseudomonas Infections / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000302:isolation & purification*; D013982:Ticarcillin / Q000097:blood / Q000494:pharmacology*; D014031:Tobramycin / Q000097:blood / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D013982:Ticarcillin; D014031:Tobramycin